By effectively restoring lysosomal acidity and autophagic flux, ATT not only counteracts chloroquine-induced cytotoxicity but also exhibits remarkable efficacy in diverse disease models, including NAFLD (via lipid droplet clearance) and Huntington’s disease (through enhanced mutant huntingtin degradation). This evidence concerns the gene HTT and metabolic dysfunction-associated steatotic liver disease.